SCHEMBL23944939

SCHEMBL23944939

CCCCCCC(C)(CCCC)CCC(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PAM P19021 2/20 0.47
DGKA P23743 1/20 0.47
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 2/20 0.40
DNM1 Q05193 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KDM4E B2RXH2 1/20 0.39
DUSP3 P51452 1/20 0.39
HTR2C P28335 1/20 0.39
NAAA Q02083 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20076183 1.00 MAPT (0.47) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20198651 0.92 MAPT (0.46) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20076474 0.85 DGKA (0.50) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20047503 0.84 CA12 (0.46) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL19861519 0.84 DGKA (0.48) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL19861159 0.84 MEN1 (0.49) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL12504498 0.82 DGKA (0.41) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL12504537 0.82 DGKA (0.41) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL12504163 0.82 DGKA (0.41) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL19861446 0.81 DGKA (0.53) MAPTMEN1KMT2AATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323913-A1 SIGMA RECEPTOR BINDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323913-A1 SIGMA RECEPTOR BINDERS SIGMAR1, OPRK1, OPRL1 MAPT 373/4885MEN1 4333/4885KMT2A 3025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.